Galectin Therapeutics
GALT
GALT
63 hedge funds and large institutions have $21.5M invested in Galectin Therapeutics in 2014 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
72% less call options, than puts
Call options by funds: $326K | Put options by funds: $1.15M
Holders
63
Holding in Top 10
–
Calls
$326K
Puts
$1.15M
Top Buyers
| 1 | +$3.4M | |
| 2 | +$716K | |
| 3 | +$479K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
+$408K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$278K |
Top Sellers
| 1 | -$4.14M | |
| 2 | -$1.92M | |
| 3 | -$1.76M | |
| 4 |
D.E. Shaw & Co
New York
|
-$456K |
| 5 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$375K |